BridgeBio Pharma (BBIO) Earnings Date, Estimates & Call Transcripts $35.68 +1.51 (+4.42%) Closing price 04:00 PM EasternExtended Trading$35.10 -0.58 (-1.61%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BridgeBio Pharma Earnings Summary BridgeBio Pharma posted Q1 2025 earnings on April 29, 2025, reporting an EPS of -$0.88, which beat analysts' consensus estimates of -$1.00 by $0.12. Quarterly revenue fell 44.8% year-over-year to $36.74 million, below the consensus estimate of $57.14 million. With a trailing EPS of -$3.53, BridgeBio Pharma's earnings are expected to grow next year, from ($3.67) to ($2.30) per share. Latest Q1 Earnings DateApr. 29EstimatedConsensus EPS (Apr. 29) -$1.00 Actual EPS (Apr. 29) -$0.88 Beat By $0.12 Actual Revenue (Apr. 29) $36.74MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get BridgeBio Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BridgeBio Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BBIO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BridgeBio Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.01-$0.69-$0.85Q2 20252-$1.08-$0.76-$0.92Q3 20252-$1.02-$0.86-$0.94Q4 20252-$1.06-$0.83-$0.95 FY 2025 8 -$4.17 -$3.14 -$3.66 Q1 20261-$0.85-$0.85-$0.85Q2 20261-$0.77-$0.77-$0.77Q3 20261-$0.73-$0.73-$0.73Q4 20261-$0.65-$0.65-$0.65 BridgeBio Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails4/29/2025Q1 2025-$1.00-$0.88+$0.12-$0.88$57.14M$36.74M2/20/2025Q4 2024-$1.09-$1.31 -$0.22-$1.40$4.04M$5.88M8/1/2024Q2 2024-$1.00-$0.39+$0.61-$1.65$3.96M$2.17M5/2/2024Q1 2024-$0.40-$0.05+$0.35$0.10$140.06M$211.12M2/22/2024Q4 2023-$0.87-$0.96 -$0.09-$0.96$4.78M$1.74M11/2/2023Q3 2023-$0.86-$1.08 -$0.22-$1.08$5.29M$4.09M8/3/2023Q2 2023-$0.80-$0.98 -$0.18-$0.98$2.99M$1.60M BridgeBio Pharma Earnings - Frequently Asked Questions When did BridgeBio Pharma announce their last quarterly earnings? BridgeBio Pharma (NASDAQ:BBIO) last announced its quarterly earning data on Tuesday, April 29, 2025. Learn more on BBIO's earnings history. Did BridgeBio Pharma beat their earnings estimates last quarter? In the previous quarter, BridgeBio Pharma (NASDAQ:BBIO) reported ($0.88) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.00) by $0.12. Learn more on analysts' earnings estimate vs. BBIO's actual earnings. How can I listen to BridgeBio Pharma's earnings conference call? The conference call for BridgeBio Pharma's latest earnings report can be listened to online. Listen to Conference Call How can I read BridgeBio Pharma's conference call transcript? The conference call transcript for BridgeBio Pharma's latest earnings report can be read online. Read Transcript How much revenue does BridgeBio Pharma generate each year? BridgeBio Pharma (NASDAQ:BBIO) has a recorded annual revenue of $127.42 million. How much profit does BridgeBio Pharma generate each year? BridgeBio Pharma (NASDAQ:BBIO) has a recorded net income of -$535.76 million. BBIO has generated -$3.53 earnings per share over the last four quarters. What is BridgeBio Pharma's EPS forecast for next year? BridgeBio Pharma's earnings are expected to grow from ($3.67) per share to ($2.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies ONC Earnings Results BNTX Earnings Results SMMT Earnings Results TEVA Earnings Results ITCI Earnings Results GMAB Earnings Results RDY Earnings Results MRNA Earnings Results ASND Earnings Results VTRS Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? This page (NASDAQ:BBIO) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredYou’re Being Set Up — Here’s Your ExitLet's not sugarcoat it — your dollars are getting weaker by the hour. Inflation, reckless debt, digital cur...American Alternative | SponsoredA New Economic Shift – How You Can PrepareWhile everyone's focused on the Fed and interest rates... most investors are missing the real story. There'...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBIO Stock Free BBIO Stock Alerts